ATRA
Atara Biotherapeutics Inc
Price:  
0.80 
USD
Volume:  
1,699,268.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atara Relative Valuation

-7009.4%
Upside

As of 2024-02-28, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (54.93) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.80 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -7009.4%.

The range of the Relative Valuation is (54.64) - (55.09) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 24.3x - 27.6x 27.5x
Forward P/E multiples 20.3x - 24.5x 21.4x
Fair Price (54.64) - (55.09) (54.93)
Upside -6972.6% - -7029.1% -7009.4%
0.80 USD
Stock Price
(54.93) USD
Fair Price

Atara Relative Valuation - Historical P/E Data

Date P/E
2024-02-27 -0.35
2024-02-26 -0.32
2024-02-23 -0.33
2024-02-22 -0.35
2024-02-21 -0.35
2024-02-20 -0.37
2024-02-16 -0.34
2024-02-15 -0.34
2024-02-14 -0.34
2024-02-13 -0.34
2024-02-12 -0.37
2024-02-09 -0.36
2024-02-08 -0.37
2024-02-07 -0.44
2024-02-06 -0.50
2024-02-05 -0.49
2024-02-02 -0.54
2024-02-01 -0.37
2024-01-31 -0.28
2024-01-30 -0.28
2024-01-29 -0.27
2024-01-26 -0.27
2024-01-25 -0.27
2024-01-24 -0.26
2024-01-23 -0.27
2024-01-22 -0.27
2024-01-19 -0.28
2024-01-18 -0.32
2024-01-17 -0.32
2024-01-16 -0.32
2024-01-12 -0.32
2024-01-11 -0.27
2024-01-10 -0.25
2024-01-09 -0.26
2024-01-08 -0.25
2024-01-05 -0.20
2024-01-04 -0.20
2024-01-03 -0.20
2024-01-02 -0.21
2023-12-29 -0.23
2023-12-28 -0.24
2023-12-27 -0.25
2023-12-26 -0.25
2023-12-22 -0.24
2023-12-21 -0.20
2023-12-20 -0.25
2023-12-19 -0.25
2023-12-18 -0.25
2023-12-15 -0.27
2023-12-14 -0.30